
Johanna C Iturrino Moreda MD
Gastrointestinal Functional & Motility Disorders
Member of the Faculty, Beth Israel Deaconess Medical Center
Join to view full profile
330 Brookline AveBoston, MA 02215
Phone+1 617-667-2137
Dr. Iturrino Moreda is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 2009 - 2012
University of Puerto RicoResidency, Internal Medicine, 2005 - 2008
University of Puerto Rico School of MedicineClass of 2005
Certifications & Licensure
MA State Medical License 2016 - 2027
NH State Medical License 2024 - 2024
MN State Medical License 2009 - 2018
WI State Medical License 2012 - 2017
PR State Medical License 2008 - 2010
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification PowerChart (Clinical), Cerner Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise, GE Healthcare, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2014, 2016-2017
Clinical Trials
- A Clinical Trial Evaluating Diets for IBS Start of enrollment: 2021 Jul 21
Roles: Contact
Publications & Presentations
PubMed
- ORP-101 in Irritable Bowel Syndrome With Diarrhea: A Phase II Randomized, Controlled Trial.Prashant Singh, Judy W Nee, Sarah Ballou, Allen Lee, Jack Loesch
Clinical Gastroenterology and Hepatology. 2026-08-01 - Clinical Symptoms Do Not Distinguish Sucrose Malabsorption From SIBO.Chethan Ramprasad, Vikram Rangan, Colin Wu, Katha Makwana, Samantha Proctor
Neurogastroenterology and Motility. 2026-04-01 - Glucagon-like Peptide-1 Receptor Agonists Are Associated With a Lower Risk of Peptic Ulcer Disease: A Nationwide Cohort Study.Philippa Seika, Jocelyn Chang, Su Min Hong, Sarah Ballou, Vikram Rangan
Clinical Gastroenterology and Hepatology. 2026-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









